Stage IVA Bladder Cancer
3 clinical trials · Condition
◉ Watch Stage IVA Bladder Cancer
| Record | Firm | Date |
|---|---|---|
| Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma (NCT03229278) | Rutgers, The State University of New Jersey | 2017-10-03 |
| MDSC Clinical Assay in Finding and Monitoring Cancer Cells in Blood and Urine Samples From Patients With or Without Localized or Metastatic Bladder Cancer (NCT02735512) | University of Southern California | 2016-03-01 |
| Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations (NCT02646319) | Mayo Clinic | 2016-01-01 |
Track Stage IVA Bladder Cancer automatically
Every clearance here is in the API, with alerts when new ones post.